(S) -2-Morpholin-4-yl-propionic acid hydrochloride

(S) -2-Morpholin-4-yl-propionic acid hydrochloride with CAS 237427-96-2 is a chiral morpholine-containing carboxylic acid hydrochloride compound. It is a white crystalline powdery fine chemical intermediate with stable chemical properties under low-temperature sealed storage. This chiral compound has high stereoselectivity, and its single enantiomer structure makes it widely used in high-precision organic synthesis and pharmaceutical research fields. It cannot be freely mixed with strong acids, strong bases and oxidants during storage and application to avoid structural destruction of chiral molecules.

(2S) -2- (Morpholin-4-yl) propanoic acid hydrochloride, (S) -2-Morpholinopropanoic acid Hydrochloride, MFCD22689280, 2- (4-Morpholinyl) -L-propanoic acid hydrochloride

2934999090

1. Pharmaceutical Chiral Intermediate Synthesis: (S) -2-Morpholin-4-yl-propionic acid hydrochloride (CAS237427-96-2) serves as a core chiral building block for the synthesis of central nervous system drugs and anti-inflammatory drugs. Its fixed S-type chiral structure ensures the stereochemical purity of downstream pharmaceutical finished products, reducing invalid isomer impurities in drug molecules. 2. Fine Organic Synthesis Research: This product is applied in laboratory asymmetric synthesis reactions, used to construct morpholine ring-containing functional molecular skeletons. It helps chemical research teams complete high-purity chiral compound preparation and reaction mechanism verification in custom organic synthesis projects. 3. Biomedical Reagent Preparation: It can be configured as a special biochemical buffer additive and chiral resolution reagent. (S) -2-Morpholin-4-yl-propionic acid hydrochloride (CAS 237427-96-2) improves the resolution efficiency of chiral drug monomers in biomedical detection and sample separation experiments. 4. Custom Chiral Compound Processing: Supporting customized synthesis of high-purity chiral derivatives for pharmaceutical R&D companies. According to customer technical indicators, we provide modified products based on the molecular structure of this hydrochloride raw material to meet targeted experimental and production demands.

≥97%

C7H14ClNO3

195.64

2 years under proper storage

White crystalline powder

Pharmaceutical Intermediate Grade, Research Grade

Not available

Not available